Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 3137Neoplasms 2472Carcinoma, Non-Small-Cell Lung 1886Prostatic Neoplasms 1635Colorectal Neoplasms 1435Lung Neoplasms 1308Multiple Myeloma 939Neoplasm Metastasis 928Leukemia, Myeloid, Acute 884Pancreatic Neoplasms 856Ovarian Neoplasms 810Melanoma 791Carcinoma, Hepatocellular 742Stomach Neoplasms 648Brain Neoplasms 641Recurrence 640Squamous Cell Carcinoma of Head and Neck 639Head and Neck Neoplasms 612Glioblastoma 573Lymphoma 550Uterine Cervical Neoplasms 545Triple Negative Breast Neoplasms 513Precursor Cell Lymphoblastic Leukemia-Lymphoma 509Carcinoma, Renal Cell 504Hematologic Neoplasms 466Endometrial Neoplasms 466Urinary Bladder Neoplasms 462Colonic Neoplasms 446Lymphoma, Non-Hodgkin 439Sarcoma 436

Interventions

Radiotherapy, Intensity-Modulated 1Immune Checkpoint Inhibitors 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Nasopharyngeal Cancinoma (NPC) × 1 year × Clear all
NCT07013461 2026-05-04

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

The University of Hong Kong-Shenzhen Hospital

Recruiting
5,000 enrolled
Head & Neck

Nasopharyngeal Cancinoma (NPC)

NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Not yet recruiting
516 enrolled
Head & Neck

Nasopharyngeal Cancinoma (NPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡